Annual Operating Expenses
$21.16 M
+$3.02 M+16.66%
December 31, 2023
Summary
- As of February 8, 2025, COCP annual total operating expenses is $21.16 million, with the most recent change of +$3.02 million (+16.66%) on December 31, 2023.
- During the last 3 years, COCP annual operating expenses has risen by +$9.56 million (+82.41%).
- COCP annual operating expenses is now -80.00% below its all-time high of $105.82 million, reached on December 31, 2016.
Performance
COCP Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$5.04 M
-$406.00 K-7.45%
September 30, 2024
Summary
- As of February 8, 2025, COCP quarterly total operating expenses is $5.04 million, with the most recent change of -$406.00 thousand (-7.45%) on September 30, 2024.
- Over the past year, COCP quarterly operating expenses has dropped by -$1.00 million (-16.56%).
- COCP quarterly operating expenses is now -94.66% below its all-time high of $94.39 million, reached on December 31, 2016.
Performance
COCP Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
COCP Operating Expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +16.7% | -16.6% |
3 y3 years | +82.4% | +12.0% |
5 y5 years | +134.6% | +12.0% |
COCP Operating Expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +48.8% | -16.6% | +36.2% |
5 y | 5-year | at high | +138.6% | -16.6% | +155.2% |
alltime | all time | -80.0% | >+9999.0% | -94.7% | +288.5% |
Cocrystal Pharma Operating Expenses History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $5.04 M(-7.5%) |
Jun 2024 | - | $5.45 M(+31.0%) |
Mar 2024 | - | $4.16 M(-26.6%) |
Dec 2023 | $21.16 M(+16.7%) | $5.67 M(-6.2%) |
Sep 2023 | - | $6.04 M(+39.3%) |
Jun 2023 | - | $4.34 M(-15.1%) |
Mar 2023 | - | $5.11 M(+13.5%) |
Dec 2022 | $18.14 M(+27.5%) | $4.50 M(-20.9%) |
Sep 2022 | - | $5.69 M(+52.4%) |
Jun 2022 | - | $3.74 M(-11.2%) |
Mar 2022 | - | $4.21 M(+13.6%) |
Dec 2021 | $14.22 M(+22.6%) | $3.70 M(-6.3%) |
Sep 2021 | - | $3.95 M(+3.3%) |
Jun 2021 | - | $3.83 M(+39.8%) |
Mar 2021 | - | $2.74 M(+38.6%) |
Dec 2020 | $11.60 M(+30.8%) | $1.98 M(-38.2%) |
Sep 2020 | - | $3.20 M(-20.1%) |
Jun 2020 | - | $4.00 M(+65.3%) |
Mar 2020 | - | $2.42 M(+8.9%) |
Dec 2019 | $8.87 M(-1.7%) | $2.22 M(-3.3%) |
Sep 2019 | - | $2.30 M(+7.4%) |
Jun 2019 | - | $2.14 M(-2.7%) |
Mar 2019 | - | $2.20 M(-8.2%) |
Dec 2018 | $9.02 M(+9.2%) | $2.40 M(-0.9%) |
Sep 2018 | - | $2.42 M(+13.5%) |
Jun 2018 | - | $2.13 M(+3.1%) |
Mar 2018 | - | $2.07 M(+12.8%) |
Dec 2017 | $8.26 M(-92.2%) | $1.83 M(-13.2%) |
Sep 2017 | - | $2.11 M(+75.8%) |
Jun 2017 | - | $1.20 M(-61.6%) |
Mar 2017 | - | $3.12 M(-96.7%) |
Dec 2016 | $105.82 M | $94.39 M(+4883.4%) |
Sep 2016 | - | $1.89 M(-54.9%) |
Jun 2016 | - | $4.20 M(-21.2%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2016 | - | $5.33 M(-88.0%) |
Dec 2015 | $54.03 M(+830.2%) | $44.37 M(+1127.8%) |
Sep 2015 | - | $3.61 M(-6.0%) |
Jun 2015 | - | $3.84 M(+75.1%) |
Mar 2015 | - | $2.19 M(+31.5%) |
Dec 2014 | $5.81 M(+42.3%) | $1.67 M(+36.9%) |
Sep 2014 | - | $1.22 M(-12.1%) |
Jun 2014 | - | $1.39 M(-9.5%) |
Mar 2014 | - | $1.53 M(+55.4%) |
Dec 2013 | $4.08 M(+59.8%) | $986.00 K(-1.9%) |
Sep 2013 | - | $1.00 M(-2.5%) |
Jun 2013 | - | $1.03 M(-2.6%) |
Mar 2013 | - | $1.06 M(-139.6%) |
Dec 2012 | $2.55 M(-61.1%) | -$2.67 M(-270.6%) |
Sep 2012 | - | $1.57 M(-11.3%) |
Jun 2012 | - | $1.77 M(-13.2%) |
Mar 2012 | - | $2.04 M(-880.0%) |
Dec 2011 | $6.57 M(-4.2%) | -$261.10 K(-106.1%) |
Sep 2011 | - | $4.30 M(+220.3%) |
Jun 2011 | - | $1.34 M(+12.4%) |
Mar 2011 | - | $1.20 M(-40.2%) |
Dec 2010 | $6.86 M(>+9900.0%) | $2.00 M(+9.4%) |
Sep 2010 | - | $1.83 M(+25.7%) |
Jun 2010 | - | $1.45 M(>+9900.0%) |
Mar 2010 | - | $3600.00(-67.0%) |
Dec 2009 | $42.80 K(-23.4%) | $10.90 K(+58.0%) |
Sep 2009 | - | $6900.00(-8.0%) |
Jun 2009 | - | $7500.00(-57.1%) |
Mar 2009 | - | $17.50 K(+94.4%) |
Dec 2008 | $55.90 K(-9.1%) | $9000.00(-3.2%) |
Sep 2008 | - | $9300.00(-39.6%) |
Jun 2008 | - | $15.40 K(-30.6%) |
Mar 2008 | - | $22.20 K(-10.5%) |
Dec 2007 | $61.50 K | $24.80 K(-16.8%) |
Sep 2007 | - | $29.80 K |
FAQ
- What is Cocrystal Pharma annual total operating expenses?
- What is the all time high annual operating expenses for Cocrystal Pharma?
- What is Cocrystal Pharma annual operating expenses year-on-year change?
- What is Cocrystal Pharma quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Cocrystal Pharma?
- What is Cocrystal Pharma quarterly operating expenses year-on-year change?
What is Cocrystal Pharma annual total operating expenses?
The current annual operating expenses of COCP is $21.16 M
What is the all time high annual operating expenses for Cocrystal Pharma?
Cocrystal Pharma all-time high annual total operating expenses is $105.82 M
What is Cocrystal Pharma annual operating expenses year-on-year change?
Over the past year, COCP annual total operating expenses has changed by +$3.02 M (+16.66%)
What is Cocrystal Pharma quarterly total operating expenses?
The current quarterly operating expenses of COCP is $5.04 M
What is the all time high quarterly operating expenses for Cocrystal Pharma?
Cocrystal Pharma all-time high quarterly total operating expenses is $94.39 M
What is Cocrystal Pharma quarterly operating expenses year-on-year change?
Over the past year, COCP quarterly total operating expenses has changed by -$1.00 M (-16.56%)